Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma
Open Access
- 11 December 2011
- journal article
- research article
- Published by Hindawi Limited in Sarcoma
- Vol. 2011, 1-8
- https://doi.org/10.1155/2011/325189
Abstract
Introduction. The symptom burden and role of palliative care (PC) in patients with advanced soft tissue sarcoma (STS) are not well defined.Methods. This study retrospectively reviewed both symptoms and PC involvement in patients known to an STS referral centre who died in one calendar year.Results. 81 patients met inclusion criteria of which 27% had locally advanced disease and 73% metastases at initial referral. The median number of symptoms was slowly progressive ranging from 2 (range 0–5) before first-line chemotherapy () to 3 (range 1–6) at the time of best supportive care (BSC) decision (). Pain and dyspnoea were the commonest symptoms. Median overall survival from BSC decision was 3.4 weeks. 88% had PC involvement (either hospital, community, or both) with median time from first PC referral to death of 16 (range 0–110) weeks.Conclusions. Patients with metastatic STS have a significant symptom burden which justifies early PC referral. Pain, including neuropathic pain, is a significant problem. Dyspnoea is common, progressive and appears to be undertreated. Time from BSC decision to death is short, and prospective studies are required to determine whether this is due to overtreatment or very rapid terminal disease progression.Keywords
This publication has 35 references indexed in Scilit:
- The Prevalence of Pain in Patients Attending Sarcoma Outpatient ClinicsSarcoma, 2011
- Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaBritish Journal of Cancer, 2011
- Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue SarcomaSarcoma, 2010
- Guidelines for the Management of Soft Tissue SarcomasSarcoma, 2010
- Variability in Access to Hospital Palliative Care in the United StatesJournal of Palliative Medicine, 2008
- Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcomaCancer, 2008
- Inequity in the provision of and access to palliative care for cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)BMC Public Health, 2007
- Survival after enrollment in an Australian palliative care programJournal of Pain and Symptom Management, 2004
- Barriers and Enablers to Hospice Referrals: An Expert OverviewJournal of Palliative Medicine, 2002
- Survival of Medicare Patients after Enrollment in Hospice ProgramsNew England Journal of Medicine, 1996